Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

Abstract: A back passivation crystalline silicon solar cell includes an Ag gate finger electrode, a SiNx passivation antireflection layer, an N+ layer, P-type silicon, a back passivation layer, and an Al gate finger electrode, connected sequentially from top to bottom. The Ag gate finger electrode sequentially penetrates through the SiNx passivation antireflection layer and the N+ layer and is connected to the P-type silicon by means of an N++ layer. The Al gate finger electrode penetrates through the back passivation layer and is connected to the P-type silicon by a P+ layer. The back passivation layer is a passivation antireflection laminated structure that includes a SiO2 passivation layer, an AlOx passivation layer, a SiNx antireflection layer, and a SiOxNy antireflection layer, sequentially provided from top to bottom. The solar cell has high carrier selectivity, high temperature stability, excellent interface passivation effect and PID resistance, high conversion efficiency and high stability.

Abstract: A small cell base station antenna includes a tubular reflector that has at least first through fourth faces that each face in different directions. The antenna further includes first through fourth arrays of radiating elements that are mounted on the respective first through fourth faces of the tubular reflector. The antenna also includes a passive beamforming network that has first through fourth outputs that are coupled to the respective first through fourth arrays of radiating elements.

Abstract: An adjusting method for stabilizing optical characteristic parameters applicable to transmitter optical subassemblies with silicon photonic chips is provided.

Abstract: A processing die and a preparation method for a fastener are provided. The processing die includes a punch and a die. The top of the punch and the bottom of the die are configured for being connected with a hydraulic press, the die includes a first half die and a second half die which are clamped to form an inlet channel, an expansion corner channel and a torsion channel, and an extrusion channel is included in the forming sliding block, the inlet channel, the expansion corner channel, the torsion channel and the extrusion channel are sequentially assembled to form a die channel cavity, and a billet to be processed is successively subjected to upsetting, shearing, torsion and extrusion in a single die under the pressure of the punch.

Abstract: The present disclosure relates to a signal processing device and a base station antenna. The signal processing device comprises: a substrate; a beam-forming network, which is provided on one side of the substrate; and a calibration circuit, which is provided on the same side of the substrate on which the beam-forming network is provided; wherein the beam-forming network is connected to the calibration circuit via a connecting trace on the substrate.

Abstract: A processing die and a preparation method for a fastener are provided. The processing die includes a punch and a die. The top of the punch and the bottom of the die are configured for being connected with a hydraulic press, the die includes a first half die and a second half die which are clamped to form an inlet channel, an expansion corner channel and a torsion channel, and an extrusion channel is included in the forming sliding block, the inlet channel, the expansion corner channel, the torsion channel and the extrusion channel are sequentially assembled to form a die channel cavity, and a billet to be processed is successively subjected to upsetting, shearing, torsion and extrusion in a single die under the pressure of the punch.

Abstract: A small cell base station antenna includes a tubular reflector that has at least first through fourth faces that each face in different directions. The antenna further includes first through fourth arrays of radiating elements that are mounted on the respective first through fourth faces of the tubular reflector. The antenna also includes a passive beamforming network that has first through fourth outputs that are coupled to the respective first through fourth arrays of radiating elements.

Abstract: An online software upgrade device for maintaining operation uninterrupted is disclosed. One embodiment includes a processing unit having first power and chip enabling pins and a controlling pin, an expansion I/O chip having second power and chip enabling pins and a controlled pin, and a pull-down resistor having a first end connecting with the first and second chip enabling pins. The first power enabling pin outputs a first power enabling signal and connects a power source, the first chip enabling pin outputs a first chip enabling signal and connects a driving pin of a controlled chip, and the controlling pin outputs an operation signal. The second power enabling pin connects with the first power enabling pin and outputs a second power enabling signal, the second chip enabling pin connects the first chip enabling pin and outputs a second chip enabling signal, and the controlled pin connects with the controlling pin.

Abstract: An online software upgrade device for maintaining operation uninterrupted is disclosed. One embodiment includes a processing unit having first power and chip enabling pins and a controlling pin, an expansion I/O chip having second power and chip enabling pins and a controlled pin, and a pull-down resistor having a first end connecting with the first and second chip enabling pins. The first power enabling pin outputs a first power enabling signal and connects a power source, the first chip enabling pin outputs a first chip enabling signal and connects a driving pin of a controlled chip, and the controlling pin outputs an operation signal. The second power enabling pin connects with the first power enabling pin and outputs a second power enabling signal, the second chip enabling pin connects the first chip enabling pin and outputs a second chip enabling signal, and the controlled pin connects with the controlling pin.

Abstract: An adjusting method for stabilizing optical characteristic parameters applicable to transmitter optical subassemblies with silicon photonic chips is provided.

Abstract: Provided herein are formulations, processes, solid forms and methods of use relating to salts of and solid forms comprising free base or salts of (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile.

Abstract: Provided herein are formulations, processes, solid forms and methods of use relating to salts of and solid forms comprising free base or salts of (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Abstract: Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.

Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.